Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Business intelligence is crucial in the decision-making process of
pharmaceutical and biopharmaceutical companies as they increase their levels
of external development and manufacturing. It also is vitally important for
contract service providers in evaluating their competitive advantage. Nice
Insight’s data facilitates that knowledge for the players in pharmaceutical
outsourcing. At Pharmaceutical Technology, we also use their research to
spot and track the trends we write about."
Michelle Hoffman Editorial Director,Pharmaceutical Drug Development and Manufacturing Group, Advanstar Pharmaceutical  
CPhI Worldwide
October 22-24 Messe Frankfurt, Germany |
Aarti Drugs Ltd. ACIC Pharmaceuticals Ajinomoto AminoScience Amsyn Asymchem Laboratories Inc. Deepwater Chemicals, Inc. Deseret Laboratories Halo Pharmaceutical Inc. Haupt Pharma AG McGean Asymchem Laboratories Inc.
Asymchem Laboratories Inc. is a contract manufacturer of APIs, intermediates, and drug products for the pharmaceutical industry. The company possesses a diverse range of capabilities ranging from the medchem scale synthesis of complex molecules to commercial scale production of APIs. The company supports organizations at all stages of pharmaceutical research and development. http://www.asymchem.com.cn
Regions
Americas, Asia Stock Symbol Private Filter of Asymchem Laboratories Inc.'s services per Nice Insight Categories
Contact Asymchem Laboratories Inc. 
|
|
|
